Diagnos Inc. | Cash Flow

Fiscal year is April-March. All values CAD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,640.80
2,827.60
3,192.40
2,929.50
2,897.20
3,839.10
Depreciation, Depletion & Amortization
62.20
43.70
82.40
192.60
230.20
191.30
Other Funds
219.50
154.50
523.40
525.90
287.00
719.70
Funds from Operations
1,359.10
2,629.40
2,586.60
2,211.00
2,572.20
2,992.70
Changes in Working Capital
145.30
237.00
84.20
45.00
321.90
348.90
Net Operating Cash Flow
1,213.80
2,866.40
2,502.40
2,166.00
2,894.20
2,643.90
Capital Expenditures
21.30
35.40
203.90
262.40
270.90
Purchase/Sale of Investments
32.10
107.20
58.60
361.20
1.20
Net Investing Cash Flow
10.80
145.20
129.60
157.50
258.80
Issuance/Reduction of Debt, Net
631.40
249.90
874.70
157.80
2,740.30
Net Financing Cash Flow
726.90
2,488.80
2,756.90
1,721.30
3,113.40
Net Change in Cash
476.00
522.90
124.90
287.20
39.60
Free Cash Flow
1,220.80
2,886.90
2,679.70
2,399.10
3,165.10
Deferred Taxes & Investment Tax Credit
-
-
-
-
192.20
64.70
Other Sources
-
-
15.70
58.70
13.30
Change in Capital Stock
95.50
2,238.90
1,882.30
1,563.60
373.10
Other Uses
-
2.50
-
-
-

About Diagnos

View Profile
Address
7005 Taschereau Boulevard
Brossard Québec J4Z 1A7
Canada
Employees -
Website http://www.diagnos.com
Updated 07/08/2019
Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company offers algorithm development, data analysis, and image processing services. It focuses on the development of its AI tool, Computer Assisted Retina Analysis (CARA), which is a tele-ophthalmology platform that integrates with existing equipment and processes at the point of care.